for
BIOL 232 Anatomy & Physiology 2
Pathogens disease-causing
microorganisms: viruses,
bacteria, protists, and fungi
Examples: HIV, HBV, HCV,
syphilis, malaria, trypanosomiasis
Of greatest concern:
Bloodborne viruses
Human immunodeficiency virus (HIV)
Hepatitis B virus (HBV)
Hepatitis C virus (HCV)
non-B, non-C Hepatitis
HIV continued
Infects multiple types of cells and especially Tlymphocytes (important immune cells)
Depletes the immune system of critical cells leading
to secondary infection and failure of tumor
suppression (due to loss of T-cells)
Multiple strains that vary in virulence, individuals also
vary in susceptibility
Weak and short-lived outside of human body fluids
(minutes-hours)
HIV continued
Within a month of exposure the infected person may
experience:
Fevers and chills
Sore muscles and joints
Night sweats
Swollen lymph nodes and rashes
HIV / AIDS
Acquired Immune Deficiency Syndrome
AIDS: secondary infections following HIV
infection, often including normally rare diseases
Pneumocystis carinii pneumonia
Kaposis sarcoma (cancer)
Candida (thrush, vaginal yeast infection)
Cytomegalovirus (usually eye infection)
Hepatitis B Virus
About 0.3% of the US population is infected (about 1
million people) annually.
Worldwide, approximately 2 billion people have been
infected at some point in their life.
Approximately 350 million are chronic carriers.
Endemic in China.
Spread primarily either among children or via maternal-fetal
transmission in regions with many chronic carriers.
Spread mainly via IV-drug needle sharing and unprotected
sex in developed nations with low infection rates and routine
childhood HBV vaccination.
HBV continued
Infects the hepatocytes of the liver leading to inflammation and cell death
mediated by cytotoxic T-lymphocytes .
Chronic infection
May cause chronic liver damage due to cirrhosis leading to death, but 90% of
cases are cured with treatment.
In some infection leads to chemotherapy-resistant liver cancer
HBV continued
The virus can persist in the environment (e.g., in dried blood for up
to a week).
The virus also persists in the body and may be reactivated in cases
of immunosuppression (e.g., transplant recipients)
Hepatitis C Virus
Infects 200-350 million people worldwide
Approximately 3-4 million new infections annually
HCV continued
HCV continued
May be persistent in the environment (e.g., in dried blood
for up to a week).
Standard treatment:
PEGylated Interferon--2a (or 2b) and ribavirin for 24-48 weeks
New drugs being developed include viramidine, and protease
inhibitors
Mode of
transmission
Virus
Needle stick
Bacteria
Sexual contact
Protist
Bite or scratch
Fungus
Ectoparasites
(some)
New
infection
Who is at risk?
Who is at risk at ONU
Biology and allied health students, staff and faculty
Athletes, coaches and trainers
Custodial and maintenance staff
RULE #1
Treat all human tissues and anything that
contacts human tissues as if they are
contaminated!
Biohazardous Material
Universal Precautions
In the lab when we are working with human body fluids do
not put anything in your mouth. In other words, no:
Eating
Drinking
Chewing gum
Engineering Controls
Self-sheathing needles
Biohazard disposal bags and boxes
gloves
wipes and paper towels
soft plastic items
Hand-washing
If hands free towel-dispensers are not available, prepare
towels in advance.
Remove rings and watches before washing.
Position the hands lower than your arms.
Use soap and copious quantities of running water.
Rub your hands vigorously under the running water for
10-15 seconds (10 sec minimum).
Wash all surfaces and rinse well.
Dry hands with disposable towels.
Hand-washing continued
When to wash hands:
After removing gloves and other PPE
After using the restroom
Before and after eating
Exposure
Report any exposure immediately to your
instructor
You may need to go to the Health Center or
your family physician for evaluation
Health center:
315 West College Avenue
(419) 772-2086